Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

12.49
-0.1100-0.87%
Post-market: 12.490.00000.00%16:05 EDT
Volume:475.53K
Turnover:5.93M
Market Cap:617.23M
PE:-3.42
High:12.74
Open:12.66
Low:12.28
Close:12.60
Loading ...
Feb 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Dec 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]